Nov 26, 2017 — 3 min read
Lunit, an AI-powered medical image analysis software company, is returning to RSNA 2017 in its second year with a new and advanced, cloud-based artificial intelligence solution for real-time image analysis一 Lunit INSIGHT. This will be the first live-demonstration of the software to the public at 2017 Radiology Society of North America Annual Meeting (RSNA), beginning November 26 through December 1 at booth #8164, North Hall, McCormick Place in Chicago.
Lunit is one of the top international medical AI companies, named in CB Insights “AI 100” startups list as one of the leaders transforming healthcare industry. Lunit has proven high-end technology, recognized at international competitions such as ImageNet (5th place, 2015), TUPAC 2016 (1st place), and Camelyon 2017 (1st place), surpassing top companies like Google, IBM, and Microsoft.
Top-notch medical AI technology at the tip of your fingers
Lunit’s AIs are trained by a huge collection of de-identified clinical data from Lunit’s partner hospitals, 18 in total number of partnerships. The total number of images that has been directly used in its research has reached over 1 million well-curated high-quality case images. With the given image data, the AI algorithms are then specifically trained to detect target diseases or radiologic findings, including lung cancer, tuberculosis, pneumonia, pneumothorax, and breast cancer for chest x-ray and mammograms.
Based on this top-notch AI technology, Lunit is to introduce , a cloud-based imaging AI platform that is currently available to the public at https://insight.lunit.io/. The platform delivers Lunit’s state-of-the-art AI models; the first one to be unveiled is the chest x-ray solution. Lunit’s chest x-ray solution detects major chest abnormalities, lung nodule/mass, consolidation, and pneumothorax, with an unprecedented high level of accuracy 一 97% standalone accuracy in nodule detection, 99% for consolidation and pneumothorax.
According to the National Lung Screening Trial (NLST), one of the largest clinical trials conducted on lung cancer screening, 26.5% of lung cancer cases were shown to be missed by chest x-ray. Worldwide, more than 1 billion chest x-ray exams are performed every year. Decreasing the proportion of missed cases even by 10% would translate into significant clinical benefit.
What’s foremost remarkable is how Lunit’s AI solutions have been proven to significantly increase the diagnostic performance of its users up to 20%, from non-radiology physicians to radiology experts. Lunit’s solutions are designed to augment the diagnostic performance level of its users as the “second reader,” not replace them.
“Lunit’s vision is to develop advanced software for medical data analysis and interpretation that goes beyond the level of human vision,” said Anthony S. Paek, CEO of Lunit. “In presenting Lunit INSIGHT, we hope to contribute in opening a new era of medical practice, by helping and empowering healthcare professionals to make more accurate, consistent, and efficient clinical decisions for the patients.”
Users can upload their medical images via online, at Lunit INSIGHT webpage. AI analysis results appear in just a few seconds, including not only the level of abnormality, but also the visualization of the AI’s attention map. Lunit’s solutions will also be presented integrated into the systems of various companies including Nuance, EnvoyAI, and Infinitt Healthcare.
“Featured” in RSNA; development in process for mammography solution
Lunit was chosen as “featured” exhibitor of RSNA in a consecutive two year since its initial presentation last year. This year, Lunit’s exhibition booth is part of the “machine learning showcase,” along with Google Cloud, NVIDIA, and other top exhibitors. On Tuesday, 28 November, Brandon B. Suh, Chief Medical Officer, will give a presentation, “Lunit INSIGHT: Toward Beyond-Human-Level AI for Medical Imaging Modalities,” at Machine Learning Theater. A press conference and demonstration at Lunit booth will be followed shortly after the presentation.
In order to launch meaningful AI solutions that has high clinical impact, proper clinical validation is an important part of the process. “Large-scale multi-center reader studies are set to be conducted in early 2018,” said Suh, Chief Medical Officer of Lunit. “These are the studies with multiple leading hospitals in Korea and the US for Lunit’s chest x-ray and mammography solutions; publication of the results are targeted for late 2018.” FDA approval for Lunit’s chest x-ray and mammography solutions are expected to be achieved by end of 2018.
Other than the chest x-ray solution, Lunit’s mammography solution to detect suspicious breast cancer lesions is in its final stages of development. Lunit INSIGHT for Mammography is expected to be publically released by the first quarter of 2018. Lunit is also doing research in developing solutions for digital breast tomosynthesis, chest CT, and coronary CT angiography.
Founded in 2013, Lunit develops advanced medical image analytics and novel imaging biomarkers via cutting-edge deep learning technology, in order to empower healthcare practitioners to make more accurate, consistent, and efficient clinical decisions. Lunit was chosen as Top AI startups in healthcare industry by CB Insights in 2017 and also was listed as “Top 5 AI startups for social impact” by Nvidia. Lunit is based in Seoul, South Korea.
Introducing: Lunit INSIGHT "The First-ever, Real-time Imaging AI Analytics on the Web"
Related filesMain PR-Lunit INSIGHT.pdf
Lunit wins Tumor Proliferation Assessment Challenge (TUPAC) 2016
Lunit to unveil data-driven imaging biomarker at RSNA 2016
Lunit to showcase AI-powered products at USCAP 2017
Lunit INSIGHT: The First-ever, Real-time Imaging AI Analytics on the Web
Cognitive biases and augmented intelligence in radiology
Lunit Returns to RSNA with Real-time Imaging Platform, Featuring Cloud-based A
Lunit INSIGHT: Q&A with Brandon B. Suh, Chief Medical Officer at Lunit
ANNOUNCING: BRANDON SUH, OUR NEW CEO
Lunit preps Korean IPO led by NH Investment Bank
Media Advisory: Lunit at RSNA 2018
Lunit Opens “Lunit INSIGHT for Mammography” for Public Access
Lunit Brings its Newest AI Solution for Mammography to RSNA 2018
Lunit Partners with Fujifilm and Salud Digna to Provide Medical AI Solution in Mexico
Lunit announces new members in its advisory board: Dr. Eliot Siegel, Dr. Linda Moy, and Dr. Khan Siddiqui
Lunit to Introduce Medical AI Solutions at GTC 2019
Lunit to Present Abstracts on AI-powered Precision Pathology at 2019 AACR Annual Meeting
Lunit to Showcase AI Solution for Breast Cancer at SBI 2019
Lunit to Present Findings on the Predictive Power of AI Biomarker for Lung Cancer Immunotherapy at ASCO 2019
Lunit Receives Korea MFDS Approval for its AI Solution for Breast Cancer, Lunit INSIGHT MMG
Lunit Named to the 2019 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
Lunit Gets Korea MFDS Approval for its AI Solution for Chest X-ray, Lunit INSIGHT CXR 2
Lunit at RSNA 2019
Lunit Announces its First CE Mark for AI-Powered Chest X-ray Analysis Software, Lunit INSIGHT CXR
Lunit AI software clinically installed in global sites—to be presented at RSNA 2019
Lunit Secures $26M in Series C Funding Round, Led by Asian Investors
AI-assisted Radiologists Can Detect More Breast Cancer with Reduced False-positive Recall
Renowned Oncologist Dr. Tony Mok Joins Lunit Advisory Board
Lunit Releases Its AI Online to Support Healthcare Professionals Manage COVID-19
Lunit to Present Findings on the Predictive Power of AI-based Analysis of Immune Phenotype at ASCO 2020
Lunit INSIGHT MMG, an AI Solution for Breast Cancer Detection, Now CE Certified
AI Solution for COVID-19, Developed by Medical AI Firm Lunit, Now Has Users in More Than 10 Countries
Lunit Awarded as Technology Pioneer by World Economic Forum
Lunit at ECR 2020: Providing Virtual Exhibition and Online Presentations
Lunit Named to the 2020 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
Emergent Connect Partners with Lunit to Provide Cloud Based AI Solutions
AI Analysis Can Improve Lung Cancer Detection on Chest Radiographs
AI has Added Value in Insurance Underwriting Process, Recent Pilot Project Between Lunit and Cathay Financial Innovation Lab Reveals
RSNA 2020--Lunit Collaborates with Global Giants in Presenting its AI Solution at Virtual Booths of GE Healthcare, FujiFilm, and Sectra
AI Proves Its Value in Assistance for Emergency Cases-- With Higher Accuracy and Timely Reporting Time of Chest Radiographs
Lunit Expands Collaboration with GE Healthcare to Advance AI Adoption across Healthcare Industry
AI Can Offer Fast and Reliable Examination to Triage COVID-19 Patients-- A Multicenter Retrospective Study Reveals
Recent Studies Reveal High Performance of Lunit AI in Breast Cancer Detection
South Korean Medical AI Provider and PACS Leader Enters Indonesian Market, to Help COVID-19 Screening and Diagnosis
What do the medical journals say about AI-powered mammography?
Research Using Lunit Demo Website
Lunit Presents AI-powered Pathologic Classification of Immune Phenotype that Predicts Response to Immunotherapy at USCAP 2021
What do the medical journals say about AI-powered chest x-ray interpretation?
Join our webinar with Dr. Fredrik Strand
From retrospective to prospective trials of AI in breast cancer screening
AACR 2021 - Lunit Presents Abstracts Demonstrating the Potential of its AI Biomarker in Cancer Treatment
Will AI Identify Breast Cancer Better Than Radiologists in Actual Clinical Screening?
Case of the Month | Where Is Breast Cancer?
AI-based Analysis of Cancer Tissue Predicts Response to Immunotherapy--Findings to Be Presented at ASCO 2021
Clinical Application of Lunit AI For Chest Radiography and Mammography to Be Presented at AOCR 2021
Lunit Secures $26M Investment from Guardant Health in a Strategic Funding Round
A Multi-reader Study Finds Unnecessary CT Exams Can Be Reduced by 30% When Analyzing Chest Radiographs with AI
Fujifilm Introduces its AI-powered Product for Chest X-ray in Japan, in Collaboration with Lunit
Lunit Collaborates with Intel to Provide AI Solutions to CPU-Based Customers in Need of Effective X-ray Diagnosis
Lunit AI Applied to Clinical Trial for Drug Development for the First Time--Findings Presented at ESMO 2021
Case of the Month (Chest x-ray)
COVID Global User Testimonials
Where is Cancer?
Evaluation curves for object detection algorithms in medical images
Lunit to Participate in RSNA 2021, Presenting its New AI Solutions for Digital Breast Tomosynthesis and Chest CT
RadLink, Singapore’s Leading Imaging Center, Adapts Lunit AI to Analyze Chest X-rays and Mammograms
Lunit Expands Team with Multiple Industry Leaders to Accelerate its Business Growth
Lunit Gets FDA Nod for AI-based Chest X-ray Triage Solution, Developed for Sorting of Emergency Cases
Lunit's AI Software for Breast Cancer Detection, Lunit INSIGHT MMG, Wins FDA Clearance
Research Backs Clinical Efficacy of Lunit's Radiology AI Products; Abstracts to be Presented at RSNA 2021
Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors
Lunit Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
Lunit Obtains MDSAP Certificate, Granted Fast-Track Regulatory Process in Major Countries
Lunit to Showcase Chest and Breast Radiology AI in Arab Health 2022
Baheya Foundation, Egypt’s Premier Destination for Breast Cancer, Adopts Lunit AI to Enhance Early Screening
Case of the Month (Chest x-ray) - Tuberculosis Case
New Studies at AACR 2022 Highlight Lunit SCOPE’s Immune Phenotyping Capabilities
Medical AI Startup Lunit gets Preliminary Approval to go Public on KOSDAQ
Lunit AI solution for PD-L1 expression analysis receives CE mark
Lunit to Present 11 Abstracts at the 2022 ASCO Annual Meeting
Lunit Files Registration Statement for Initial Public Offering
Lunit AI Solution for Radiology Receives Health Canada Nod for Commercial Use